Anemia Is a Predictor of Outcome in Heart Transplant Recipients

Transplantation Proceedings

Volumn 41, Issue 8, 2009, Pages 3228-3231

  Przybylowski, P ^a   Malyszko, J ^b,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AZATHIOPRINE; CREATININE; CYCLOSPORIN; EVEROLIMUS; HEMOGLOBIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ANEMIA; ARTICLE; CARDIAC GRAFT REJECTION; CARDIOMYOPATHY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE ASSOCIATION; ERYTHROCYTE; ERYTHROCYTE COUNT; FEMALE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ANEMIA; BLOOD PRESSURE; CREATININE; ERYTHROCYTE COUNT; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; LEUKOCYTE COUNT; LIPIDS; MIDDLE AGED; PREVALENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350441160     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.07.076     Document Type: Article

References (22)

1. O'Meara E., Clayton T., McEntegart M.B., et al. CHARM Committee and Investigators: Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Circulation 113 (2006) 986
2. Silverberg D.S., Wexler D., Blum M., et al. The interaction between heart failure, renal failure and anemia: the cardio-renal anemia syndrome. Blood Purif 22 (2004) 277
3. McClellan W.M., Flanders W.D., Langston R.D., et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 13 (2002) 1928
4. Silverberg D.S., Wexler D., Blum M., et al. The cardiorenal syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. Clin Nephrol 60 suppl 1 (2003) S93
5. Wexler D., Silverberg D., and Sheps D. Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure. Int J Cardiol 96 (2004) 79
6. Silverberg D.S., Wexler D., Blum M., et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 35 (2000) 1737
7. Winkelmayer W.C., and Chandraker A. Pottransplantation anemia: management and rationale. Clin J Am Soc Nephrol 3 suppl 2 (2008) S49
8. Mix T.C., Kazmi W., Khan S., et al. Anemia: a continuing problem following kidney transplantation. Am J Transplant 3 (2003) 1426
9. Joist H., Brennan D.C., and Coyne D.W. Anemia in the kidney-transplant patient. Adv Chronic Kid Dis 13 (2006) 4
10. Reyes C.J., Evangelista L.S., Doering L., et al. Physical and psychological attributes of fatigue in female heart transplant recipients. J Heart Lung Transplant 23 (2004) 614
11. Bergen G.A., Sakalosky P.E., and Sinnott J.T. Transient aplastic anemia caused by parvovirus B19 infection in a heart transplant recipient. J Heart Lung Transplant 15 (1996) 843
12. Lammermeier D.E., Duncan J.M., Kuykendall R.C., et al. Cardiac transplantation in a Jehovah's Witness. Tex Heart Inst J 15 (1988) 189
13. National Kidney Foundation. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kid Dis 39 (2002) S1
14. World Health Organization. Nutritional anaemias: report of a WHO scientific group (1968), World Health Organization, Geneva, Switzerland
15. Horwich T.B., Fonarow G.C., Hamilton M.A., et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 39 (2002) 1780
16. Anand I.S. Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 52 (2008) 501
17. Androne A.S., Katz S.D., Lund L., et al. Hemodilution is common in patients with advanced heart failure. Circulation 107 (2003) 226
18. Felker G.M., Adams Jr. K.F., Gattis W.A., et al. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 44 (2004) 959
19. Winkelmayer W.C., Kewalramani R., Rutstein M., et al. Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol 15 (2004) 1347
20. Imoagene-Oyedeji A.E., Rosas S.E., Doyle A.M., et al. Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality. J Am Soc Nephrol 17 (2006) 3240
21. Zakliczyński M., Szewczyk M., Zakliczyńska H., et al. Clinical application of monitoring mycophenolic acid trough concentration in heart transplant recipients: single center's experience. Ann Transplant 10 (2005) 38
22. Taegtmeyer A.B., Rogers P., Breen J.B., et al. The effects of pre- and post-transplant anemia on 1-year survival after cardiac transplantation. J Heart Lung Transplant 27 (2008) 394